Clinical trial

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

NCT00530920

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-10-01

PhasePHASE2

Study timeline

Study start (unknown)2007-10-01Date precision: month

Registry last updated2014-06-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

tipranavirDRUG · verified · RxNorm: tipranavir

ritonavirDRUG · verified · RxNorm: ritonavir

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

BarcelonaSpain2 BerlinGermany2 MadridSpain1 MünchenGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00530920 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.